Cat Breast Tumors Mirror Ours Genetically, and the Cure Talk Never Left the Dish

The tissue came from cats who were already sick. Somewhere a vet had found a lump, cut it out and sent it off for a diagnosis before moving on to the next appointment, and the sample went into storage with nobody imagining it would end up in a research paper. Repeat that ordinary moment for almost 500 pet cats in five countries and you have the raw material for the paper published in Science on 19 February by researchers at the Wellcome Sanger Institute, the Ontario Veterinary College and the University of Bern. It was the first time anyone had genetically profiled cat tumors at that scale, and it was built entirely from tissue vets had already collected for diagnosis.

Newsweek had its version up the same afternoon, describing similarities between cat and human breast cancers that “could possibly lead to a cure for both.” When the study came round the health feeds again in September, ScienceDaily ran it under the headline “Scientists say house cats could help unlock better cancer treatments for humans.” The paper is better than either headline and considerably smaller, and the distance between the two can be measured fairly precisely.

The team screened about 1,000 genes that have direct counterparts among known human cancer genes, comparing tumor tissue against healthy tissue across 13 cancer types. TP53, the gene most often mutated in human cancers, came out on top in cats as well. The richest findings came from feline mammary carcinoma, which the Sanger Institute calls “a common and aggressive type of cancer in cats” and which, according to Bern’s Sven Rottenberg, already resembles triple-negative human breast cancer. The researchers expected to find BRCA1, the breast-cancer gene most readers can name, in those tumors. “Surprisingly, however, this was not the case,” Rottenberg said.

They found seven driver genes in the mammary tumors instead. The most common was FBXW7, changed in over 50 percent of them, followed by PIK3CA at 47 percent, according to the Sanger Institute. In human breast cancer, changes in FBXW7 are associated with a worse prognosis, and that parallel between species is what a cancer biologist would notice first.

The practical result is a freely available database of feline cancer genetics, the first of its kind, which any lab can now use. Louise Van Der Weyden of the Sanger Institute, the senior author, called it “one of the biggest ever developments in feline oncology,” and for once a superlative in a press release holds up. She also spelled out what it was for: helping cats “to catch up with the diagnostic and therapeutic options that are available for dogs with cancer.” That is a promise to cats, and a sensible one.

The line from this work to a human cure runs through one experiment. Chang He, a PhD student in Rottenberg’s Bern group and a co-first author, grew mammary tumors as “tumoroids,” three-dimensional cell-culture models, and reported that “vinca alkaloids were markedly more effective in feline tumoroids with FBXW7 mutations.” An earlier study had found that human leukemia cells without working FBXW7 respond well to the same class of drugs, so the Bern team suggests that cats with FBXW7-mutated tumors could model a clinically relevant subset of human breast cancer. That is a fair hypothesis, and the authors labeled it as one. The Sanger release says the drug work was “conducted in tissue samples, and requires further investigation,” and a footnote adds: “This was not a clinical trial.”

Rottenberg described the study as “an important bridge between veterinary and human medicine.” Whatever else that means, it is not a treatment. The road from a drug-sensitive culture in an incubator to a treated patient, feline or human, is long, and plenty of promising cancer leads have stalled on it. Newsweek and ScienceDaily both mentioned, further down the page, that the drug result came only from tissue samples. The caveat made it into both articles. It did not make it into either headline.

There is a stronger argument for human relevance in the release, and it got less attention than the cure talk. “Our household pets share the same spaces as us, meaning that they are also exposed to the same environmental factors,” said Geoffrey Wood of the Ontario Veterinary College, a co-senior author. A cat on the sofa breathes the same air and drinks the same water as its owner. If the two species turn out to develop the same tumors through the same genes, the shared environment becomes a question worth chasing, though it is a much less marketable one than a cure.

The funding is disclosed and worth reading through. Alongside Wellcome, Canada’s NSERC, the Swiss National Science Foundation and the EveryCat Health Foundation, the work was backed by CVS Group, which describes itself as “a listed provider of veterinary services in the UK and Australia,” with about 500 practices, nine specialist-led referral hospitals and its own diagnostic laboratories. There’s nothing sinister about that, and a vet chain paying for basic science is more than most companies manage. It does show where the near-term money in this research lies. A company of that size has an obvious interest in a future where a cat’s lump gets sequenced before it gets treated, which is roughly what Van Der Weyden’s phrase “precision feline oncology” would look like in a waiting room.

What the evidence supports is modest and true. Cats get cancers that look genetically like ours, and there is now a public map showing it. Anything beyond that, for a human patient, is a hypothesis tested on cat tissue in a dish. When Van Der Weyden measured what her team had built, she compared cats with dogs, not with people. Of all the ambitions attached to this paper, hers is the only one the data fully supports.

Sources

1. Wellcome Sanger Institute: Household cat could hold the key to understanding breast cancer
2. University of Bern: Domestic cats may hold the key to understanding breast cancer
3. ScienceDaily: Scientists say house cats could help unlock better cancer treatments for humans
4. Newsweek: Scientists studied 500 cats. What they learnt could help treat cancer
5. CVS Group: About us
6. Francis, Ludwig, He, et al., “The oncogenome of the domestic cat,” Science, 19 February 2026 (DOI 10.1126/science.ady6651)